2-147920262-A-C

Variant summary

Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate

The NM_001616.5(ACVR2A):ā€‹c.995A>Cā€‹(p.Asn332Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000137 in 1,461,274 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā˜…).

Frequency

Genomes: not found (cov: 32)
Exomes š‘“: 0.0000014 ( 0 hom. )

Consequence

ACVR2A
NM_001616.5 missense

Scores

4
15

Clinical Significance

Uncertain significance criteria provided, single submitter U:1

Conservation

PhyloP100: 2.05
Variant links:
Genes affected
ACVR2A (HGNC:173): (activin A receptor type 2A) This gene encodes a receptor that mediates the functions of activins, which are members of the transforming growth factor-beta (TGF-beta) superfamily involved in diverse biological processes. The encoded protein is a transmembrane serine-threonine kinase receptor which mediates signaling by forming heterodimeric complexes with various combinations of type I and type II receptors and ligands in a cell-specific manner. The encoded type II receptor is primarily involved in ligand-binding and includes an extracellular ligand-binding domain, a transmembrane domain and a cytoplasmic serine-threonine kinase domain. This gene may be associated with susceptibility to preeclampsia, a pregnancy-related disease which can result in maternal and fetal morbidity and mortality. Alternative splicing results in multiple transcript variants of this gene. [provided by RefSeq, Jun 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Uncertain_significance. Variant got 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.22490671).

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect #exon/exons MANE UniProt
ACVR2ANM_001616.5 linkuse as main transcriptc.995A>C p.Asn332Thr missense_variant 8/11 ENST00000241416.12
ACVR2ANM_001278579.2 linkuse as main transcriptc.995A>C p.Asn332Thr missense_variant 9/12
ACVR2ANM_001278580.2 linkuse as main transcriptc.671A>C p.Asn224Thr missense_variant 8/11
ACVR2AXM_047446292.1 linkuse as main transcriptc.671A>C p.Asn224Thr missense_variant 8/11

Ensembl

Gene Transcript HGVSc HGVSp Effect #exon/exons TSL MANE Appris UniProt
ACVR2AENST00000241416.12 linkuse as main transcriptc.995A>C p.Asn332Thr missense_variant 8/111 NM_001616.5 P1P27037-1
ACVR2AENST00000404590.1 linkuse as main transcriptc.995A>C p.Asn332Thr missense_variant 9/121 P1P27037-1
ACVR2AENST00000535787.5 linkuse as main transcriptc.671A>C p.Asn224Thr missense_variant 8/112 P27037-2

Frequencies

GnomAD3 genomes
Cov.:
32
GnomAD3 exomes
AF:
0.00000399
AC:
1
AN:
250554
Hom.:
0
AF XY:
0.00000739
AC XY:
1
AN XY:
135406
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00000884
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000137
AC:
2
AN:
1461274
Hom.:
0
Cov.:
30
AF XY:
0.00000275
AC XY:
2
AN XY:
726922
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.00
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00000180
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
32
Alfa
AF:
0.000111
Hom.:
0
EpiCase
AF:
0.0000546
EpiControl
AF:
0.00

ClinVar

Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

not specified Uncertain:1
Uncertain significance, criteria provided, single submitterclinical testingAmbry GeneticsOct 05, 2022The c.995A>C (p.N332T) alteration is located in exon 8 (coding exon 8) of the ACVR2A gene. This alteration results from a A to C substitution at nucleotide position 995, causing the asparagine (N) at amino acid position 332 to be replaced by a threonine (T). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.094
BayesDel_addAF
Benign
-0.11
T
BayesDel_noAF
Benign
-0.40
CADD
Benign
20
DANN
Uncertain
0.98
DEOGEN2
Benign
0.24
T;.;T
Eigen
Benign
-0.11
Eigen_PC
Benign
0.077
FATHMM_MKL
Uncertain
0.95
D
LIST_S2
Uncertain
0.87
.;D;D
M_CAP
Benign
0.015
T
MetaRNN
Benign
0.22
T;T;T
MetaSVM
Benign
-0.89
T
MutationAssessor
Benign
1.2
L;.;L
MutationTaster
Benign
1.0
D;D;D
PrimateAI
Uncertain
0.78
T
PROVEAN
Benign
-2.2
N;N;N
REVEL
Benign
0.098
Sift
Benign
0.31
T;T;T
Sift4G
Benign
0.41
T;T;T
Polyphen
0.0
B;.;B
Vest4
0.30
MutPred
0.51
Loss of stability (P = 0.0973);.;Loss of stability (P = 0.0973);
MVP
0.43
MPC
0.79
ClinPred
0.39
T
GERP RS
5.4
Varity_R
0.35
gMVP
0.71

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs1558814473; hg19: chr2-148677831; API